Research in the neurosciences is in the midst of a particularly exciting period of discovery, says Zach Hall, director of the National Institute of Neurological Disorders and Stroke (NINDS), as ...
Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Note: Hover over the donut graph to view ...
GAITHERSBURG, Md., Oct. 06, 2022 (GLOBE NEWSWIRE) -- NexImmune (NEXI), Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate ...
COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle, Andelyn Biosciences, Inc., and AmplifyBio, have been awarded a new task order from the National Institute of Neurological Disorders and Stroke (NINDS) to ...
BERWYN, Pa.--(BUSINESS WIRE)--Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic ...
A Northeast Arkansas based company, SylamoreBio, has received a $3 million Phase II Small Business Innovation Research (SBIR) ...
RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...
For the first time, researchers have recorded pain-related data from inside the brain of individuals with chronic pain disorders caused by stroke or amputation (phantom limb pain). A long sought-after ...
Temporal lobe epilepsy is a seizure disorder that may result from head trauma, childhood injuries, tumors, brain malformations, and infections. Karen Wilcox, PhD, Chair of Pharmacology and Toxicology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback